Cancer Safety Fears Of Most Common Heartburn Treatment Proton Pump Inhibitors (PPI) Rejected By Major Clinical Study At Queen Mary School of Medicine And University of London
Medical News Today -- Fears about the cancer causing effects of the second most prescribed group of drugs in the Western world have been put to rest, following the largest ever study into their use.
